Chief Science Officer and Co-Founder, RecovryAI
Appears in 1 story
Leading FDA submission preparation
In August 2026, the FDA's device center published a discussion paper on how to regulate generative AI medical devices and asked for public comment. The paper is the agency's most concrete step toward formal rules for a technology it has never authorized in a commercial device.
Updated Oct 17
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
